Treatment of Cardiovascular Implantable Electronic Device Infection with Daptomycin
AHMAD F. JEBRAN M.D.
Department of Thoracic and Cardiovascular Surgery, University of Göttingen, Germany
Search for more papers by this authorCorresponding Author
ARON F. POPOV M.D.
Department of Thoracic and Cardiovascular Surgery, University of Göttingen, Germany
Department of Cardiothoracic Transplantation & Mechanical support, Royal Brompton & Harefield Hospitals, London, United Kingdom
Address for reprints: Aron-Frederik Popov, M.D., Department of Thoracic and Cardiovascular Surgery, University of Göttingen, Robert-Koch-Straße 40, 37099 Göttingen, Germany. Fax: 49551 396002; e-mail: [email protected]Search for more papers by this authorDIETER ZENKER M.D.
Department of Thoracic and Cardiovascular Surgery, University of Göttingen, Germany
Search for more papers by this authorCHRISTIAN BIRETA M.D.
Department of Thoracic and Cardiovascular Surgery, University of Göttingen, Germany
Search for more papers by this authorDIRENDRA RAJARUTHNAM M.D.
Department of Cardiothoracic Transplantation & Mechanical support, Royal Brompton & Harefield Hospitals, London, United Kingdom
Search for more papers by this authorMARTIN FRIEDRICH M.D.
Department of Thoracic and Cardiovascular Surgery, University of Göttingen, Germany
Search for more papers by this authorFRIEDRICH A. SCHOENDUBE M.D., Ph.D.
Department of Thoracic and Cardiovascular Surgery, University of Göttingen, Germany
Search for more papers by this authorAHMAD F. JEBRAN M.D.
Department of Thoracic and Cardiovascular Surgery, University of Göttingen, Germany
Search for more papers by this authorCorresponding Author
ARON F. POPOV M.D.
Department of Thoracic and Cardiovascular Surgery, University of Göttingen, Germany
Department of Cardiothoracic Transplantation & Mechanical support, Royal Brompton & Harefield Hospitals, London, United Kingdom
Address for reprints: Aron-Frederik Popov, M.D., Department of Thoracic and Cardiovascular Surgery, University of Göttingen, Robert-Koch-Straße 40, 37099 Göttingen, Germany. Fax: 49551 396002; e-mail: [email protected]Search for more papers by this authorDIETER ZENKER M.D.
Department of Thoracic and Cardiovascular Surgery, University of Göttingen, Germany
Search for more papers by this authorCHRISTIAN BIRETA M.D.
Department of Thoracic and Cardiovascular Surgery, University of Göttingen, Germany
Search for more papers by this authorDIRENDRA RAJARUTHNAM M.D.
Department of Cardiothoracic Transplantation & Mechanical support, Royal Brompton & Harefield Hospitals, London, United Kingdom
Search for more papers by this authorMARTIN FRIEDRICH M.D.
Department of Thoracic and Cardiovascular Surgery, University of Göttingen, Germany
Search for more papers by this authorFRIEDRICH A. SCHOENDUBE M.D., Ph.D.
Department of Thoracic and Cardiovascular Surgery, University of Göttingen, Germany
Search for more papers by this authorAbstract
We describe a case of 83-year-old man who was admitted to our department for treatment of recurrent device-pocket infections. Our report shows that in a case of high-risk patient with a complicated cardiac implantable electric devices infection involving multidrug-resistent gram-positive pathogen, the application of daptomycin in combination with staged surgical therapy can be efficient and safe. PACE 2012; 35:e105–e107)
References
- 1 Smit J, Korup E, Schønheyder HC. Infections associated with permanent pacemakers and implanted cardioverter-defibrillator devices. A 10-year regional study in Denmark. Scand J Infect Dis 2010; 42: 658–664.
- 2 Tarakji KG, Chan EJ, Cantillon DJ, Doonan AL, Hu T, Schmitt S, Fraser TG, et al. Cardiac implantable electronic device infections: Presentation, management, and patient outcomes. Heart Rhythm 2010; 7: 1043–1047.
- 3 Bloom H, Heeke B, Leon A, Mera F, Delurgio D, Beshai J, Langberg J. Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery. Pacing Clin Electrophysiol 2006; 29: 142–145.
- 4 Chu VH, Crosslin DR, Friedman JY, Reed SD, Cabell CH, Griffiths RI, Masselink LE, et al. Staphylococcus aureus bacteremia in patients with prosthetic devices: Costs and outcomes. Am J Med 2005; 118: 1416
- 5 Vogt PR, Sagdic K, Lachat M, Candinas R, von Segesser LK, Turina MI. Surgical management of infected permanent transvenous pacemaker systems: Ten year experience. J Card Surg 1996; 11: 180–186.
- 6 Wilkoff BL. How to treat and identify device infections. Heart Rhythm 2007; 4: 1467–1470.
- 7 Baddour LM, Epstein AE, Erickson CC, Knight BP, Levison ME, Lockhart PB, Masoudi FA, et al. American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee; Council on Cardiovascular Disease in Young; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Nursing; Council on Clinical Cardiology; Interdisciplinary Council on Quality of Care; American Heart Association. Update on cardiovascular implantable electronic device infections and their management: A scientific statement from the American Heart Association. Circulation 2010; 121: 458–477.
- 8 Kanafani ZA, Corey GR. Daptomycin: A rapidly bactericidal lipopeptide for the treatment of gram-positive infections. Expert Rev Anti Infect Ther 2007; 5: 177–184.
- 9 Steenbergen JN, Alder J, Thorne GM, Tally FP. Daptomycin: A lipopeptide antibiotic for the treatment of serious gram-positive infections. J Antimicrob Chemother 2005; 55: 283–288.
- 10 Bell JM, Turnidge JD, Sader HS, Jones RN. Antimicrobial activity and spectrum of daptomycin: Results from the surveillance program in Australia and New Zealand (2008). Pathology 2010; 42: 470–473.
- 11 Popov AF, Schmitto JD, Tirilomis T, Bireta C, Coskun KO, Mokashi SA, Emmert A, et al. Daptomycin as a possible new treatment option for surgical management of methicillin-resistant Staphylococcus aureus sternal wound infection after cardiac surgery. J Cardiothorac Surg 2010; 5: 57.
- 12 Schmitto JD, Popov AF, Sossalla ST, Coskun KO, Mokashi SA, Wintner A, Schoendube FA. Daptomycin for treatment of methicillin-resistant Staphylococcus epidermidis saphenectomy wound infection after coronary artery bypass graft operation (CABG): A case report. J Cardiothorac Surg 2009; 4: 47.
- 13 Weis F, Beiras-Fernandez A, Kaczmarek I, Sodian R, Vicol C, Reichart B, Weis M. Daptomycin for eradication of a systemic infection with a methicillin-resistant Staphylococcus aureus in a biventricular assist device recipient. Ann Thorac Surg 2007; 84: 269–270.
- 14 Chaftari AM, Hachem R, Mulanovich V, Chemaly RF, Adachi J, Jacobson K, Jiang Y, et al. Efficacy and safety of daptomycin in the treatment of gram-positive catheter-related bloodstream infections in cancer patients. Int J Antimicrob Agents 2010; 36: 182–186.
- 15 Beiras-Fernandez A, Kur F, Kiefer S, Sodian R, Schmoeckel M, Weis M, Reichart B, et al. Multidrug-resistant gram-positive infections in patients with ventricular assist devices: The role of daptomycin. Transplant Proc 2009; 41: 2589–2591.
- 16 Braun MU, Rauwolf T, Bock M, Kappert U, Boscheri A, Schnabel A, Strasser RH. Percutaneous lead implantation connected to an external device in stimulation-dependent patients with systemic infection-a prospective and controlled study. Pacing Clin Electrophysiol 2006; 29: 875–879.
- 17 Rastan AJ, Doll N, Walther T, Mohr FW. Pacemaker dependent patients with device infection-a modified approach. Eur J Cardiothorac Surg 2005; 27: 1116–1118.
Citing Literature
